Agilent Touts 'Substantial' Market Potential of Impending Target-Enrichment Kit

The company will make its debut in the target-enrichment market on the heels of Roche NimbleGen, which markets an array-based sequence-capture kit, and Raindance Technologies, which last week launched an in-solution sequence-enrichment product.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.